Dr. Di Wu from CHOP will give us a talk on next Wednesday.
Title: Quantitative pharmacology of buprenorphine
pharmacotherapy in newborns with neonatal abstinence syndrome: a case study on how developmental changes affect clinical trial dose optimization.
Outlines:
1. Develop population pharmacokinetic models to establish dose and exposure relationship of buprenorphine (BUP) & its major metabolite—norbuprenorphine (NBUP);
2. Evaluate how the developmental changes affect population modeling in term infants.
The talk will still be held at CRB 302, 12:00 ~ 1:00PM.
